Atorvastatin Calcium Tablets

DRUG4 trials

Conditions

COVID-19 Post-Intensive Care SyndromeCOVID-19 Respiratory InfectionCOVID-19 Stress SyndromeCOVID-19 Vaccine Adverse ReactionCOVID-19-Associated StrokeCOVID-19-Associated ThromboembolismCoronary Heart DiseaseMetabolism Disorder, Glucose

Phase 1

COVID-19 Vaccination Detoxification in LDL-C

NCT05839236

Yang I. PachankisCOVID-19-Associated Stroke, COVID-19-Associated Thromboembolism, COVID-19 Post-Intensive Care Syndrome +3

Start: 2023-05-01End: 2023-07-31Updated: 2023-05-06

Phase 4

Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes

CompletedNCT05238012

Heart Health Research CenterMetabolism Disorder, Glucose, Metabolism Disorder, Lipid

Start: 2022-08-02End: 2024-04-02Updated: 2024-05-21

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

RecruitingNCT05641753

NYU Langone HealthType 1 Diabetes

Start: 2022-12-06End: 2027-07-31Target: 125Updated: 2025-12-29

Unknown Phase

Weak Pulse at Yang and Wiry Pulse at Yin Theory

CompletedNCT07378228

Xikun LiCoronary Heart Disease, Stable Angina Pectoris

Start: 2023-07-01End: 2024-06-01Updated: 2026-01-30

Related Papers

Neuropathic Pains in the Age of Post-COVID-19-Vaccination